ANGIEX Trademark Information

Trademark by Angiex, Inc.

Pharmaceutical research and development; Development of pharmaceutical preparations, medicines, and diagnostics; Research in the field of drugs and diagnostic preparations for detecting, imaging and treating cancer; Conducting early evaluations in the field of new pharmaceuticals and diagnostics preparations

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: 3/1/2017
First Use In Commerce: 3/1/2017
General Information
Word mark: ANGIEX
Status/Status Date:
REGISTERED
7/4/2017
Estimated Renewal Deadline: July 4, 2023
Serial Number: 86948315
Filing Date: 3/22/2016
Registration Number: 5237897
Registration Date: 7/4/2017
Goods and Services: Pharmaceutical research and development; Development of pharmaceutical preparations, medicines, and diagnostics; Research in the field of drugs and diagnostic preparations for detecting, imaging and treating cancer; Conducting early evaluations in the field of new pharmaceuticals and diagnostics preparations
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 9/6/2016
Last Applicant/Owner:
Angiex, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
REGISTERED
7/4/2017
Correspondent Search:
KEITH TOMS, ESQUIRE is a correspondent of ANGIEX trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on